Tinea Capitis: Current Status
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Tinea capitis remains a common childhood infection in many parts of the world. Yet knowledge of the underlying pathogenetic mechanisms and the development of effective immunity have shown striking advances, and new methods of diagnosis ranging from dermoscopy to molecular laboratory tests have been developed even though they have not been assimilated into routine practice in many centres. Treatment is effective although it needs to be given for at least 1 month. What is missing, however, is a systematic approach to control through case ascertainment and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent review revealed a change in the last 1–2 decades, the spread of Trichophyton tonsurans as the dominant agent of tinea capitis, in the Americas, UK, Europe and Africa [173].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [173]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tinea capitis is a common superficial infection of the scalp hair caused by dermatophyte fungi; occurring predominantly in children [172,173].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [173]
The cited source says what the claim attributes to it.
In the citing paper
“Tinea capitis can be caused by a variety of anthropophilic or zoophilic Trichophyton or Microsporum species.”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [173]
The cited source says what the claim attributes to it.
In the citing paper
“The species of dermatophyte implicated in tinea capitis infections vary from geographic region to region. In turn, this pattern also changes with time, particularly as new organisms are introduced by migration or immigration [173].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [173]
The cited source says what the claim attributes to it.
In the citing paper
“Its clinical manifestations range from mild scaling with little hair loss to large inflammatory and pustular plaques with extensive alopecia [173].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [173]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Dermatophytosis and Inherited CARD9 Deficiency
Lanternier, F., Pathan, S., Vincent, Q. B., Liu, L., Cypowyj, S., Prando, C., Migaud, M., Taibi, L., Ammar-Khodja, A., Boudghene Stambouli, O., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208487 · Cited by 400 · cited 1×
“Control of tinea capitis is not impossible, and with current understanding of the immunology and host susceptibility, including the latest findings of specific CARD 9 gene mutations associated with widespread deep dermatophytosis [38], it is theoretically possible to develop an immunizing antigen.”
BackgroundSelf-citationTinea capitis: A current perspective
Elewski, B. E. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90001-x · Cited by 383 · cited 12×
“tonsurans in urban communities in the USA [1] andWestern Europe, e.”
BackgroundInfluentialBritish Association of Dermatologists' guidelines for the management of tinea capitis 2014
Fuller, L. C., Barton, R. C., Mohd Mustapa, M. F., Proudfoot, L. E., Punjabi, S. P., Higgins, E. M., Hughes, J. R., Sahota, A., Griffiths, M., McDonagh, A. J., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13196 · Cited by 206
Systemic antifungal therapy for tinea capitis in children
Chen, X., Jiang, X., Yang, M., González, U., Lin, X., Hua, X., Xue, S., Zhang, M., & Bennett, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004685.pub3 · Cited by 184
Cutaneous defenses against dermatophytes and yeasts
Wagner, D. K., & Sohnle, P. G. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.3.317 · Cited by 180 · cited 1×
“Other innate inhibitory mechanisms, important in the scalp, include medium chain length fatty acids in sebum which are inhibitory to dermatophyte growth [8].”
BackgroundNiyonsaba, F., & Ogawa, H. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.07.009 · Cited by 165 · cited 1×
“The expression of naturally produced antimicrobial peptides, including human b-defensins (hBDs), cathelicidin LL-37 and dermicidin [6], provides a major source of innate defence.”
BackgroundTinea capitis in Europe: new perspective on an old problem
Hay, R. J., Robles, W. S., Midgley, G., & Mk, M. (2001) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2001.00214.x · Cited by 130 · cited 1×
“In turn, this pattern may change with time, particularly as new organisms are introduced by migration or immigration [1, 17, 18].”
BackgroundSelf-citationEvaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans
Babel, D. E., & Baughman, S. A. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70331-5 · Cited by 123 · cited 1×
“If they are positive on culture but the scalp is clinically normal, they are described as carriers [35] and most advise treating them with antifungal shampoos as described above.”
BackgroundAdherence of Dermatophyte Microconidia and Arthroconidia to Human Keratinocytes In Vitro
Zurita, J., & Hay, R. J. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12461067 · Cited by 108 · cited 1×
“This has been shown to be a time-dependent process in which the invading arthrospore is attached to an underlying keratinocyte over a 2–3 h period before germination [2].”
BackgroundSelf-citationStaib, P., Zaugg, C., Mignon, B. R., Weber, J., Grumbt, M., Pradervand, S., Harshman, K., & Monod, M. (2009) · Microbiology · doi:10.1099/mic.0.033464-0 · Cited by 97 · cited 2×
“Proteases with keratinase activity from certain dermatophytes are inducible by low-molecular-weight peptides released from the epidermal cells by the action of other fungal proteinases [4].”
Background
Research works printed but not linked: 1
- Calderon RA Hay RJ Cell-mediated immunity in experimental murine dermatophytosis. I: T-suppressor activity elicited in dermatophyte infections caused by T. quinckeanum Immunology 1984 53 457 464 6237986 PMC1454919
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“Its clinical manifestations range from mild scaling with little hair loss to large inflammatory and pustular plaques with extensive alopecia [173].”
BackgroundInfluentialAnti-Fungal Efficacy and Mechanisms of Flavonoids
Al Aboody, M. S., & Mickymaray, S. (2020) · Antibiotics · doi:10.3390/antibiotics9020045 · Cited by 472
“It is especially prominent in subSaharan Africans [63,64].”
BackgroundThe role of the microbiome in scalp hair follicle biology and disease
Polak‐Witka, K., Rudnicka, L., Blume‐Peytavi, U., & Vogt, A. (2019) · Experimental Dermatology · doi:10.1111/exd.13935 · Cited by 173
Current Topics in Dermatophyte Classification and Clinical Diagnosis
Moskaluk, A. E., & VandeWoude, S. (2022) · Pathogens · doi:10.3390/pathogens11090957 · Cited by 186
Chanyachailert, P., Leeyaphan, C., & Bunyaratavej, S. (2023) · Journal of Fungi · doi:10.3390/jof9060669 · Cited by 225
Metadata
- Authors
- Hay, R. J.
- Affiliations
- King's College Hospital (GB)
- Corresponding author
- Hay, R. J.
- ORCID
- Hay, R. J.
- Venue
- Mycopathologia
- Published
- 2016-09-06
- Volume
- 182
- Issue
- 1-2
- Pages
- 87-93
- ISSN
- 0301-486X (ISSN-L)
- 1573-0832
- PMC
- PMC5283510
- OpenAlex
- W2509292936
- Cited by
- 277
- References
- 41
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 31 · 2023: 51 · 2022: 42 · 2021: 37 · 2020: 39 · 2019: 19 · 2018: 9 · 2017: 9 · 2016: 1
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Mycopathologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- tinea capitis, pathogenesis, host immunity, dermoscopy, molecular diagnosis, antifungal therapy, case ascertainment, disease control
- MeSH terms
- Antifungal Agents, Arthrodermataceae, Diagnostic Tests, Routine, Humans, Tinea Capitis, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tinea Capitis: Current Status. https://app.cochat.ai/papers/10.1007/s11046-016-0058-8
- The paper
- Hay, R. J. (2017). Tinea Capitis: Current Status. Mycopathologia. https://doi.org/10.1007/s11046-016-0058-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.